BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19370689)

  • 1. Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis.
    Amin R; Noone PG; Ratjen F
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007481. PubMed ID: 19370689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis.
    Amin R; Noone PG; Ratjen F
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD007481. PubMed ID: 23235645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis.
    Thornton J; Rangaraj S
    Cochrane Database Syst Rev; 2012 Mar; (3):CD006838. PubMed ID: 22419317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological agents (anti-inflammatory and analgesic) for managing symptoms in people with cystic fibrosis-related arthritis.
    Thornton J; Rangaraj S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006838. PubMed ID: 18254117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
    Plummer A; Wildman M
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006682. PubMed ID: 21249681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
    Fernandes B; Plummer A; Wildman M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006682. PubMed ID: 18425963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteral tube feeding for cystic fibrosis.
    Conway SP; Morton A; Wolfe S
    Cochrane Database Syst Rev; 2008 Apr; (2):CD001198. PubMed ID: 18425869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
    Plummer A; Wildman M
    Cochrane Database Syst Rev; 2013 May; (5):CD006682. PubMed ID: 23728662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis.
    Jagannath VA; Asokan GV; Fedorowicz Z; Singaram JS; Lee TW
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008139. PubMed ID: 20238363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumothorax in cystic fibrosis: beyond the guidelines.
    Lord RW; Jones AM; Webb AK; Barry PJ
    Paediatr Respir Rev; 2016 Aug; 20 Suppl():30-3. PubMed ID: 27374621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis.
    Thornton J; Rangaraj S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007336. PubMed ID: 19160333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Totally implantable vascular access devices for cystic fibrosis.
    A-Rahman A; Spencer D
    Cochrane Database Syst Rev; 2003; (3):CD004111. PubMed ID: 12918004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin and oral agents for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004730. PubMed ID: 16034943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis.
    Thornton J; Rangaraj S
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD006838. PubMed ID: 26798057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis.
    Jagannath VA; Asokan GV; Fedorowicz Z; Lee TW
    Cochrane Database Syst Rev; 2014 Feb; (2):CD008139. PubMed ID: 24515341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin A supplementation for cystic fibrosis.
    O'Neil C; Shevill E; Chang AB
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006751. PubMed ID: 18254115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin A supplementation for cystic fibrosis.
    Bonifant CM; Shevill E; Chang AB
    Cochrane Database Syst Rev; 2012 Aug; (8):CD006751. PubMed ID: 22895955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Totally implantable vascular access devices for cystic fibrosis.
    A-Rahman AK; Spencer D
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD004111. PubMed ID: 22592694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin A supplementation for cystic fibrosis.
    Bonifant CM; Shevill E; Chang AB
    Cochrane Database Syst Rev; 2014 May; (5):CD006751. PubMed ID: 24823814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral calorie supplements for cystic fibrosis.
    Smyth R; Walters S
    Cochrane Database Syst Rev; 2000; (2):CD000406. PubMed ID: 10796716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.